Immunology, Microbiology & IBD


Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

HLA-Cw*1202-B*5201-DRB1*1502 Haplotype Increases Risk for Ulcerative Colitis but Reduces Risk for Crohn's Disease

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

View All

Education & Meetings

Crohn's Disease Virtual Clinic: Alexander Visit 1

Nutrition Toolkit Series: Nutrition and Food Allergies

Protect Your Bottom Line & Achieve Excellence: The AGA Digestive Health Recognition Program Webinar

View All

Journal Articles & Editorials

Diet and Inflammatory Bowel Disease: Review of Patient-Targeted Recommendations

Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases

View All


Gastroenterology Podcast September 2014: Vedolizumab for Crohn’s Patients After TNF Therapy Has Failed

CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response

Gastroenterology Podcast April 2014: Anti-Tumor Necrosis Factor Monotherapy vs Combination Therapy for Inflammatory Bowel Disease

View All

IBD Resource Center

Pioneering research from the AGA journals on the biology and clinical management of IBD. Original research, reviews, multimedia and more. Visit the AGA Journals' IBD Resource Center.